Peer Review reports
From: Targeting CD33 for acute myeloid leukemia therapy
| Original Submission | ||
|---|---|---|
| 14 Sep 2021 | Submitted | Original manuscript |
| 7 Oct 2021 | Reviewed | Reviewer Report - Tristan Knight |
| 8 Oct 2021 | Reviewed | Reviewer Report |
| 11 Nov 2021 | Author responded | Author comments - Jing jing liu |
| Resubmission - Version 2 | ||
| 11 Nov 2021 | Submitted | Manuscript version 2 |
| 16 Nov 2021 | Reviewed | Reviewer Report - Tristan Knight |
| 17 Nov 2021 | Reviewed | Reviewer Report |
| 3 Dec 2021 | Author responded | Author comments - Jing jing liu |
| Resubmission - Version 3 | ||
| 3 Dec 2021 | Submitted | Manuscript version 3 |
| 7 Dec 2021 | Reviewed | Reviewer Report |
| 11 Dec 2021 | Author responded | Author comments - Jing jing liu |
| Resubmission - Version 4 | ||
| 11 Dec 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 15 Dec 2021 | Editorially accepted | |
| 3 Jan 2022 | Article published | 10.1186/s12885-021-09116-5 |
You can find further information about peer review here.